Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abeona Therapeutics (ABEO) Current Leases (2019 - 2025)

Abeona Therapeutics (ABEO) has 7 years of Current Leases data on record, last reported at $102000.0 in Q3 2025.

  • For Q3 2025, Current Leases fell 90.35% year-over-year to $102000.0; the TTM value through Sep 2025 reached $102000.0, down 90.35%, while the annual FY2024 figure was $823000.0, 17.54% down from the prior year.
  • Current Leases reached $102000.0 in Q3 2025 per ABEO's latest filing, down from $537000.0 in the prior quarter.
  • Across five years, Current Leases topped out at $1.8 million in Q1 2022 and bottomed at $102000.0 in Q3 2025.
  • Average Current Leases over 5 years is $1.4 million, with a median of $1.7 million recorded in 2021.
  • Peak YoY movement for Current Leases: rose 12.21% in 2024, then crashed 90.35% in 2025.
  • A 5-year view of Current Leases shows it stood at $1.8 million in 2021, then dropped by 2.48% to $1.8 million in 2022, then plummeted by 43.71% to $998000.0 in 2023, then decreased by 17.54% to $823000.0 in 2024, then crashed by 87.61% to $102000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Current Leases were $102000.0 in Q3 2025, $537000.0 in Q2 2025, and $613000.0 in Q1 2025.